Skip to content
Search

Latest Stories

UK space technologies to boost NHS Coronavirus relief efforts

The UK Space Agency has launched a new drive on Tuesday (14) to fund space-enabled technology and services that can strengthen the NHS response to coronavirus.

An initial £2.6 million is being made available to fund a number of projects to develop hi-tech solutions to the challenges, in a joint initiative with the European Space Agency (ESA) in support of NHS England.


Satellite data and drone technology can help meet challenges such as delivering test kits, masks, gowns and goggles, managing infectious disease outbreaks to support the country’s health sector.

The space-enabled solutions could include satellite communications, satellite navigation, Earth observation satellites or technology derived from human spaceflight.

Science Minister Amanda Solloway said: “From new advanced software helping speed up cancer diagnoses to satellite communications connecting GPs to patients virtually, the UK space sector has been world leading in applying its innovations to supporting our brilliant NHS.

“This new funding will ensure that the latest innovations will be on the frontline of tackling the unique problems the coronavirus outbreak has created, helping medical staff to focus on delivering world-class care.”

Meanwhile the UK Space Agency’s international partnership programme uses UK expertise to support healthcare projects all over the world, including forecasting and providing early warning of dengue fever outbreaks in Vietnam through Earth observation satellites and using telecommunications to extend the reach of basic medical healthcare into remote areas in Nigeria.

Space is already playing an important part in healthcare. UK start-up company Lanterne recently announced a free app to help people observe social distancing to slow the spread of coronavirus, using GPS satellite data and AI technologies.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less